As of 2025-07-08, the Fair Value of Cue Biopharma Inc (CUE) is -2.69 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.70 USD, the upside of Cue Biopharma Inc is -484.61%.
With the market price of 0.70 USD and our fair value calculation, Cue Biopharma Inc (CUE) is not a good investment. Investing in CUE stocks now will result in a potential loss of 484.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -44.78 | -44.16 | -53.01 | -50.73 | -40.67 | -46.67 |
| YoY growth | -22.02% | 1.38% | -20.04% | 4.30% | 19.83% | -3.31% |
| Market Cap (mil) | 52.76 |
| P/E | |
| Forward P/E |
| EPS | -0.54 |
| Avg earnings growth rate | -3.31% |
| TTM earnings | -40.58 |